Logo Image
News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health PerspectivesShorts
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
Our June 2026 print issue|
Free Webinar: The Economics of Cell and Gene Therapy |
2026 ASCO Annual Meeting|
2026 State of Pharmacy survey results available now
Advertisement

Robert Rouse, Head of US Market Access, CSL Behring

Advertisement

Articles by Robert Rouse, Head of US Market Access, CSL Behring

The value of Innovative Medicine: The clinical and economic impact of the first gene therapy for hemophilia B

ByAmbrose Carrejo, PharmD ,Pharmaceutical Contracting Leader, Kaiser Permanente (retired),Robert Rouse, Head of US Market Access, CSL Behring
November 27th 2023

Sponsored Content

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Managed Healthcare Executive

    1

    CagriSema reduces HbA1c, weight across T2D spectrum in REIMAGINE trials | ADA 2026

    2

    The women’s health conversation still has a migraine-sized gap

    3

    ALK-Positive NSCLC: Epidemiology, Prognosis, and the Critical Role of Biomarker Testing

    4

    Food as medicine programs changing diabetes care in pediatric and adult patients | ADA 2026

    5

    ALK Testing Strategies and Navigating First-Line Treatment Options in Advanced NSCLC

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • Formulary Watch
    • Pharmacy Benefit Management Institute
    Managed Healthcare Executive
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us